House hearings: Sebelius's mea culpa, Oz and Chicken Little

Share this article:

During testimony today, HHS Secretary Kathleen Sebelius promised that glitches preventing most people from shopping for coverage on the Healthcare.gov would be resolved by the end of November, and offered some steps the government is taking to fix flaws in the portal, which Republicans have used as a touchstone for their dislike of the Affordable Care Act.

But perhaps what's drawn the most attention from the press corps was her response during a fiery exchange with Rep. Marsha Blackburn (R-TN), who grilled Sebelius as to who is “responsible for this debacle.” Replied Sebelius, “Hold me accountable.”

As CBSNews.com noted, that was a departure from Sebelius's prepared remarks, which included no such mea culpa. It followed a similar apology given by CMS head Marilyn Tavenner in front of Ways and Means the day prior.

Lack of beta testing and technical snafus weren't the only thing she took heat for. Lawmakers also questioned Sebelius as to why millions of Americans are losing plans on the individual market when the President assured the public that they could keep their coverage. (Those who bought their own coverage before the law was signed can indeed keep it, she said, referring to a technicality in the law allowing them to be “grandfathered.”)

Dems countered GOP jabs like that of Rep. Joe Barton (R-TX), “Madam Secretary, while you're from Kansas, we're not in Kansas anymore. Some might say that we are actually in the Wizard of Oz land,” with clichés of their own, like Rep. Frank Pallone's (D-NJ) assertion that his colleagues on the other side of the aisle were acting like Chicken Little, except that, “my Republican colleagues are actually rooting for the sky to fall.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Genentech shift could prove costly for hospitals

Genentech will use specialty distributors rather than wholesalers, hospitals pharmacy directors have learned.

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies